ALL HYPOTHESES
Repurposing candidates for IDMF
Pancreatic cancer 2
| Mediator | Outcome | Score | Tier | Lit. status | Trial | |
|---|---|---|---|---|---|---|
| Nrf2 | chemoresistance | 0.220 | Mid | novel signal | none | |
| NRF2 | chemoresistance | 0.220 | Mid | novel signal | none |
Rheumatoid arthritis 2
| Mediator | Outcome | Score | Tier | Lit. status | Trial | |
|---|---|---|---|---|---|---|
| Nrf2 | disease activity | 0.220 | Mid | novel signal | none | |
| Nrf2 | rheumatoid arthritis | 0.220 | Mid | novel signal | none |
No registered trials found on ClinicalTrials.gov. This could indicate either an unexplored indication or a gap in registry coverage.
Search ClinicalTrials.gov →